comparemela.com

Latest Breaking News On - Company targeting on or before - Page 1 : comparemela.com

Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia

No Impact on Cash, Cash Equivalents and Marketable Investments, Cash Runway or Business OperationsCompany Targeting On or Before March 14, 2024 to File Amended Financial Statements and Report Fourth.

Christine cassianoCorporate affairs brand strategyAllogene therapeutics incExchange commissionCompany formCompany targeting on or beforeCash equivalentsMarketable investmentsCash runwayBefore marchFile amended financial statementsReport fourth quarterFull yearAllogene overland biopharmSouth san franciscoForward looking statements

Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash

No Impact on Cash, Cash Equivalents and Marketable Investments, Cash Runway or Business OperationsCompany Targeting On or Before March 14, 2024 to File Amended Financial Statements and Report Fourth Quarter

Christine cassianoCompany formCompany targeting on or beforeCorporate affairs brand strategy officerAllogene therapeutics incExchange commissionCash equivalentsMarketable investmentsCash runwayBefore marchFile amended financial statementsReport fourth quarterFull yearAllogene overland biopharmSouth san franciscoForward looking statements

vimarsana © 2020. All Rights Reserved.